2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 327-335

  Fisher, Michael T ^a   Nagarkatti, Mitzi ^a   Nagarkatti, Prakash S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CD8 ANTIGEN; HY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; T LYMPHOCYTE; THYMOCYTE; THYMUS ATROPHY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL MOVEMENT; FEMALE; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SEX CHARACTERISTICS; T-LYMPHOCYTES; TETRACHLORODIBENZODIOXIN; THYMUS GLAND;

EID: 11244331752     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005868     Document Type: Article

References (47)

1. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, et al. (1996) Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84:551-562.
2. Ashton-Rickardt PG, Bandeira A, Delaney JR, Van Kaer L, Pircher HP, Zinkernagel RM, and Tonegawa S (1994) Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651-663.
3. Camacho IA, Hassuneh MR, Nagarkatti M, and Nagarkatti PS (2001) Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 165:51-63.
4. Camacho IA, Nagarkatti M, and Nagarkatti PS (2002) 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Arch Toxicol 76:570-580.
5. Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, and Inghirami G (1999) CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol 163:194-205.
6. Dave VP, Allman D, Wiest DL, and Kappes DJ (1999) Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection. J Immunol 162:5764-5774.
7. Davis JW 2nd, Lauer FT, Burdick AD, Hudson LG, and Burchiel SW (2001) Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production. Cancer Res 61:3314-3320.
8. Dearstyne EA and Kerkvliet NI (2002) Mechanism of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas and TNF. Toxicology 170:139-151.
9. DeYoung AL, Duramad O, and Winoto A (2000) The TNF receptor family member CD30 is not essential for negative selection. J Immunol 165:6170-6173.
10. Fisher MT, Nagarkatti M, and Nagarkatti PS (2004) Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol Sci 78:116-124.
11. Granger SW and Rickert S (2003) LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 14:289-296.
12. Grassman JA, Masten SA, Walker NJ, and Lucier GW (1998) Animal models of human response to dioxins. Environ Health Perspect 106 (Suppl 2):761-775.
13. Hogquist KA (2001) Signal strength in thymic selection and lineage commitment. Curr Opin Immunol 13:225-231.
14. Jameson SC, Hogquist KA, and Bevan MJ (1995) Positive selection of thymocytes. Annu Rev Immunol 13:93-126.
15. Jeon MS and Esser C (2000) The marine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 165:6975-6983.
16. Kamath AB, Camacho I, Nagarkatti PS, and Nagarkatti M (1999) Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160:141-155.
17. Kamath AB, Nagarkatti PS, and Nagarkatti M (1998) Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol Appl Pharmacol 150:117-124.
18. Kamath AB, Xu H, Nagarkatti PS, and Nagarkatti M (1997) Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl Pharmacol 142:367-377.
19. Kerkvliet NI (2002) Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2:277-291.
20. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, and von Boehmer H (1988) Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (Lond) 333:742-746.
21. Kronenberg S, Lai Z, and Esser C (2000) Generation of alphabeta T-cell receptor+ CD4- CD8+ cells in major histocompatibility complex class-I deficient mice upon activation of the aryl hydrocarbon receptor by 2,3,7,8- tetrachlorodibenzo-p-dioxin. Immunology 100:185-193.
22. Kwon MJ, Jeong KS, Choi EJ, and Lee BH (2003) 2,3,7,8-Tetrachlorodibenzo- p-dioxin (TCDD)-induced activation of mitogen-activated protein kinase signaling pathway in Jurkat T cells. Pharmacol Toxicol 93:186-190.
23. Lacorazza HD, Tucek-Szabo C, Vasovic LV, Remus K, and Nikolich-Zugich J (2001) Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development. J Immunol 166:3184-3193.
24. Lai ZW, Fiore NC, Gasiewicz TA, and Silverstone AE (1998) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diethylstilbestrol affect thymocytes at different stages of development in fetal thymus organ culture. Toxicol Appl Pharmacol 149:167-177.
25. Lai ZW, Fiore NC, Hahn PJ, Gasiewicz TA, and Silverstone AE (2000) Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p- dioxin on thymocyte differentiation, proliferation and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol Appl Pharmacol 168:15-24.
26. Lai ZW, Hundeiker C, Gleichmann E, and Esser C (1997) Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 52:30-37.
27. Laiosa MD, Wyman A, Murante FG, Fiore NC, Staples JE, Gasiewicz TA, and Silverstone AE (2003) Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. J Immunol 171:4582-4591.
28. Mariathasan S, Ho SS, Zakarian A, and Ohashi PS (2000) Degree of ERK activation influences both positive and negative thymocyte selection. Eur J Immunol 30:1060-1068.
29. Mariathasan S, Zakarian A, Bouchard D, Michie AM, Zuniga-Pflucker JC, and Ohashi PS (2001) Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J Immunol 167:4966-4973.
30. Markiewicz MA, Girao C, Opferman JT, Sun J, Hu Q, Agulnik AA, Bishop CE, Thompson CB, and Ashton-Rickardt PG (1998) Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc Natl Acad Sci USA 95:3065-3070.
31. Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, and Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control and apoptosis. Biochem Pharmacol 59:65-85.
32. Paustenbach DJ (2002) The U.S. EPA Science Advisory Board Evaluation (2001) of the EPA dioxin reassessment. Regul Toxicol Pharmacol 36:211-219.
33. Ramakrishna G, Perella C, Birely L, Diwan BA, Fornwald LW, and Anderson LM (2002) Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 179:21-34.
34. Rhile MJ, Nagarkatti M, and Nagarkatti PS (1996) Role of Fas apoptosis and MHC genes in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity of T cells. Toxicology 110:153-167.
35. Rowlands JC and Gustafsson JA (1997) Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27:109-134.
36. Sebzda E, Kundig TM, Thomson CT, Aoki K, Mak SY, Mayer JP, Zamborelli T, Nathenson SG, and Ohashi PS (1996) Mature T cell reactivity altered by peptide agonist that induces positive selection. J Exp Med 183:1093-1104.
37. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, and Ohashi PS (1999) Selection of the T cell repertoire. Annu Rev Immunol 17:829-874.
38. Sebzda E, Wallace VA, Mayer J, Yeung RS, Mak TW, and Ohashi PS (1994) Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (Wash DC) 263:1615-1618.
39. Silverstone AE, Frazier DE Jr, Fiore NC, Soults JA, and Gasiewicz TA (1994) Dexamethasone, beta-estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol 126:248-259.
40. Sprent J and Kishimoto H (2002) The thymus and negative selection. Immunol Rev 185:126-135.
41. Sprent J and Kosaka H (1993) T cell tolerance and self/nonself discrimination. Autoimmunity 15:155-161.
42. Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H, and von Boehmer H (1988) Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature (Lond) 335:229-233.
43. Tsukumo S, Iwata M, Tohyama C, and Nohara K (2002) Skewed differentiation of thymocytes toward CD8 T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires activation of the extracellular signal-related kinase pathway. Arch Toxicol 76:335-343.
44. Vos JG, De Heer C, and Van Loveren H (1997) Immunotoxic effects of TCDD and toxic equivalency factors. Teratog Carcinog Mutagen 17:275-284.
45. Wang J, Chun T, Lo JC, Wu Q, Wang Y, Foster A, Roca K, Chen M, Tamada K, Chen L, et al. (2001) The critical role of LIGHT, a TNF family member, in T cell development. J Immunol 167:5099-5105.
46. Wang J and Fu YX (2003) LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J Immunol 170:3986-3993.
47. Yao EF and Denison MS (1992) DNA sequence determinants for binding of transformed Ah receptor to a dioxin-responsive enhancer. Biochemistry 31:5060-5067.